{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:10:47Z","timestamp":1760044247427,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.jaad.2009.02.031","type":"journal-article","created":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T05:09:32Z","timestamp":1260940172000},"page":"161-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efalizumab-induced bullous pemphigoid"],"prefix":"10.1016","volume":"62","author":[{"given":"Tu Anh","family":"Duong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Buffard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Revuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Roujeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.02.031_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1517\/14740338.5.2.197","article-title":"Efalizumab: a review of events reported during clinical trials and side effects","volume":"5","author":"Scheinfeld","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaad.2009.02.031_bib2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1365-4632.2006.02861.x","article-title":"Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship?","volume":"45","author":"Wilczek","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2009.02.031_bib3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-2133.2008.08548.x","article-title":"Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis","volume":"158","author":"Leonardi","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.02.031_bib4","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2008.01.021","article-title":"Delayed autoimmune hemolytic anemia in efalizumab-treated psoriasis","volume":"58","author":"Kwan","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.02.031_bib5","first-page":"10","article-title":"Efalizumab: progressive multifocal leukoencephalopathy (first case) in an elderly patient: case report","volume":"1223","year":"2008","journal-title":"Reactions"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209002539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209002539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:14:40Z","timestamp":1759270480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209002539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0190962209002539"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.02.031","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efalizumab-induced bullous pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.02.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}